Related Experiment Video
Updated: Jul 6, 2026
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Chrysin Attenuates Myocardial Cell Apoptosis in Mice
Gang Deng1,2, Yongzheng Yang1,3, Ouyang Qing1,3
1Department of Cardiac Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong Cardiovascular Institute, Guangzhou, 510100, Guangdong, China.
Insights
Chrysin, a natural flavonoid, protects against myocardial infarction (MI) by reducing heart cell death and fibrosis. These findings support chrysin as a potential novel therapeutic agent for treating MI.
Area of Science:
- Cardiovascular Biology
- Natural Product Chemistry
- Molecular Medicine
Background:
- Myocardial infarction (MI) involves heart muscle necrosis due to ischemia and hypoxia.
- Current treatments for MI have limitations, necessitating novel therapeutic strategies.
- Chrysin, a flavonoid from natural sources, possesses known beneficial bioactivities.
Purpose of the Study:
- To investigate the cardioprotective mechanisms of chrysin in myocardial infarction models.
- To elucidate the molecular pathways modulated by chrysin in the context of cardiac injury.
- To assess the potential of chrysin as a therapeutic agent for myocardial infarction.
Main Methods:
- Myocardial infarction (MI) and ischemia-reperfusion models were employed.
- Molecular analyses included Western blotting, immunofluorescence, and qPCR.
- Autodocking simulations were utilized to explore molecular interactions.
Main Results:
- Chrysin reduced cardiomyocyte apoptosis by modulating the Bax/Bcl-2 ratio and inhibiting caspase-3 activation via PPAR-γ.
- Chrysin mitigated cardiac fibrosis by downregulating TGF-β1, collagen I, and α-SMA.
- Chrysin improved cardiac function and reduced infarct size, linked to PPAR-γ, SIRT3, and β-catenin pathway activation.
Conclusions:
- Chrysin demonstrates significant cardioprotective effects in preclinical MI models.
- The mechanisms involve anti-apoptotic, anti-fibrotic, and signaling pathway modulation.
- Chrysin shows promise as a novel therapeutic candidate for myocardial infarction treatment.
Abstract:
Myocardial infarction (MI), induced by ischemia and hypoxia of the coronary arteries, presents as myocardial necrosis. Patients often experience intense, prolonged retrosternal pain that is unrelieved by rest or nitrate therapy and is frequently associated with high blood myocardial enzyme levels. Physical effort may exacerbate this anxiety, increasing the likelihood of life-threatening consequences such as arrhythmias, shock, or cardiac failure. Chrysin, a natural flavonoid primarily found in honey and propolis, exhibits anti-inflammatory, antioxidant, anticancer, and antiviral properties. This study utilized MI models and various analytical techniques, including Western blotting, immunofluorescence, quantitative polymerase chain reaction (qPCR), and autodocking, to elucidate the molecular mechanisms underlying the action of chrysin in molecular interactions. Our results demonstrated that Chrysin alleviates apoptosis in cardiomyocytes by decreasing the Bax/Bcl-2 ratio and suppressing caspase-3 activation, actions facilitated by PPAR-γ activation and consequent overexpression of anti-apoptotic proteins. Furthermore, chrysin mitigates cardiac fibrosis by downregulating TGF-β1, collagen I, and α-SMA expression. These effects markedly diminish infarct size and improve heart function in ischemia-reperfusion damage models, ascribed to chrysin's activation of PPAR-γ and SIRT3, together with the regulation of β-catenin pathways. The preclinical data presented in this research establish a foundation for forthcoming clinical studies to assess the safety and effectiveness of chrysin in patients with myocardial infarction. This may facilitate the development of a novel treatment approach for treating MI.
